ILANIT 2023

Viruses inhibit TIR gcADPR signaling to overcome bacterial defense

Erez Yirmiya 1 Azita Leavitt 1 Gil Amitai 1 Allen Lu 2,4 Jeremy Garb 1 Ehud Herbst 1 Benjamin R. Morehouse 2,4 Samuel J. Hobbs 2,4 Sadie P. Antine 2,4 Zhen-Yu J. Sun 3 Philip J. Kranzusch 2,4,5 Rotem Sorek 1
1Molecular Genetics, Weizmann Institute of Science, Israel
2Cancer Immunology and Virology, Dana-Farber Cancer Institute, USA
3Department of Cancer Biology, Dana-Farber Cancer Institute, USA
4Department of Microbiology, Harvard Medical School, USA
5Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, USA

The Toll/interleukin-1 receptor (TIR) domain is a key component of immune receptors that identify pathogen invasion in bacteria, plants, and animals. In the bacterial antiphage system Thoeris, as well as in plants, recognition of infection stimulates TIR domains to produce an immune signaling molecule whose molecular structure remained elusive. This molecule binds and activates the Thoeris immune effector, which then executes the immune function. We identified a large family of phage-encoded proteins, denoted here Thoeris anti-defense 1 (Tad1), that inhibit Thoeris immunity. We found that Tad1 proteins are “sponges” that bind and sequester the immune signaling molecule produced by TIR-domain proteins, thus decoupling phage sensing from immune effector activation and rendering Thoeris inactive. Tad1 can also efficiently sequester molecules derived from a plant TIR-domain protein, and a high-resolution crystal structure of Tad1 bound to a plant-derived molecule revealed a unique chemical structure of 1``–2` glycocyclic ADPR (gcADPR). Our data furthermore suggest that Thoeris TIR proteins produce a closely related molecule, 1``–3` gcADPR, which activates ThsA an order of magnitude more efficiently than the plant-derived 1``–2` gcADPR. Our results define the chemical structure of a central immune signaling molecule, and reveal a new mode of action by which pathogens can suppress host immunity.